(Q40607751)

English

Increased transcriptional activity of the CYP3A4*1B promoter variant

scientific article published on January 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Increased transcriptional activity of the CYP3A4*1B promoter variant (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

author name string

Amirimani B

1

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Ning B

2

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Deitz AC

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Weber BL

4

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Kadlubar FF

5

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Rebbeck TR

6

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Environmental and Molecular Mutagenesis

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

299-305

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

RESPONSE: re: modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4

1 reference

https://api.crossref.org/works/10.1002%2FEM.10199

7 January 2021

based on heuristic

inferred from DOI database lookup

Re: Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4

1 reference

https://api.crossref.org/works/10.1002%2FEM.10199

7 January 2021

based on heuristic

inferred from DOI database lookup

Population distribution and effects on drug metabolism of a genetic variant in the 5' promoter region of CYP3A4

1 reference

https://api.crossref.org/works/10.1002%2FEM.10199

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions

1 reference

https://api.crossref.org/works/10.1002%2FEM.10199

7 January 2021

based on heuristic

inferred from DOI database lookup

A Restriction Fragment Length Polymorphism Assay That Differentiates HumanN-Acetyltransferase-1 (NAT1) Alleles

1 reference

https://api.crossref.org/works/10.1002%2FEM.10199

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of CYP3A4 genotype with treatment-related leukemia

1 reference

https://api.crossref.org/works/10.1002%2FEM.10199

7 January 2021

based on heuristic

inferred from DOI database lookup

Genotype???phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women

1 reference

https://api.crossref.org/works/10.1002%2FEM.10199

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacogenetic phenotyping and genotyping. Present status and future potential.

1 reference

https://api.crossref.org/works/10.1002%2FEM.10199

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene structure of CYP3A4, an adult-specific form of cytochrome P450 in human livers, and its transcriptional control.

1 reference

https://api.crossref.org/works/10.1002%2FEM.10199

7 January 2021

based on heuristic

inferred from DOI database lookup

CYP gene polymorphisms and early menarche

1 reference

https://api.crossref.org/works/10.1002%2FEM.10199

7 January 2021

based on heuristic

inferred from DOI database lookup

Common allelic variants of cytochrome P4503A4 and their prevalence in different populations

1 reference

https://api.crossref.org/works/10.1002%2FEM.10199

7 January 2021

based on heuristic

inferred from DOI database lookup

The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions

1 reference

https://api.crossref.org/works/10.1002%2FEM.10199

7 January 2021

based on heuristic

inferred from DOI database lookup

Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4.

1 reference

https://api.crossref.org/works/10.1002%2FEM.10199

7 January 2021

based on heuristic

inferred from DOI database lookup

The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FEM.10199

7 January 2021

based on heuristic

inferred from DOI database lookup

Interindividual differences in hepatic expression of CYP3A4: relationship to genetic polymorphism in the 5'-upstream regulatory region

1 reference

https://api.crossref.org/works/10.1002%2FEM.10199

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/EM.10199

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40607751&oldid=1903630064"